CIK 0001576885 · <br>Emerging growth company
Acumen Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ABOS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364108129
- Phone
- 617-344-4190
- Business address
- 1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- CERT Other Certification
- 8-A12B Other Registration of Securities
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- DRS/A Other Draft Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS/A Other Draft Registration Statement
- DRS Other Draft Registration Statement
- D Other Notice of Sales of Unregistered Securities
Page 5 of 5 · 93 filings